The HLA Complex

  • Janardan P. Pandey

Abstract

The major histocompatibility complex (MHC) in man, termed HLA, is a highly polymorphic multigene system located on the short arm of chromosome 6 (Fig. 143–1). Most phenomena associated with the MHC are immunologic in nature, but it has also been associated with some that cannot readily be claimed by immunology (e.g., 21-hydroxylase deficiency). At least three classes of molecules are controlled by the MHC. Class I molecules, HLA-A, -B, and -C, are responsible for graft rejection and regulate the killing of virus-infected cells. Class II molecules, encoded by at least four loci, D, DR, DC, and SB, control communication between lymphoid cells. The HLA-A,B,C determinants are present on most nucleated tissues, whereas D-related antigens are found mainly on B lymphocytes and macrophages. Finally, class III molecules are components of the serum complement system, C2, C4A, C4B, and Bf; these proteins participate in cell lysis. The MHC loci are very closely linked (crossing over less than 1%).

Keywords

Arthritis Hepatitis Carbohydrate Recombination Polypeptide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Klein J: Immunology: The Science of Self-Nonself Discrimination. New York, John Wiley & Sons, 1982Google Scholar
  2. 2.
    Morton NE: Sequential tests for detection of linkage. Am J Hum Genet 7: 277–318, 1955PubMedGoogle Scholar
  3. 3.
    Ott J: Estimation of the recombination fraction in human pedigrees: Efficient computation of the likelihood for human linkage studies. Am J Hum Genet 26: 588–597, 1974PubMedGoogle Scholar
  4. 4.
    Levitan M, Montagu A: Textbook of Human Genetics. New York, Oxford University Press, 1971Google Scholar
  5. 5.
    Morton NE, Lalouel JM: Resolution of linkage for irregular phenotype systems. Hum Hered 31: 3–7, 1981PubMedCrossRefGoogle Scholar
  6. 6.
    Suarez BK: The affected sib pair IBD distribution for HLA-linked disease susceptibility genes. Tissue Antigens 12: 87–93, 1978PubMedCrossRefGoogle Scholar
  7. 7.
    Armitage F: Statistical Methods in Medical Research. New York, John Wiley & Sons, 1971Google Scholar
  8. 8.
    Woolf B: On estimating the relation between blood group and disease. Ann Hum Genet 19: 251–253, 1955PubMedCrossRefGoogle Scholar
  9. 9.
    Green A: The epidemiologic approach to studies of association between HLA and disease. Tissue Antigens 19: 259–268, 1982PubMedCrossRefGoogle Scholar
  10. 10.
    Terasaki PI, Park MS, Bernoco D, et al: Overview of the 1980 Histocompatibility Workshop, in Terasaki PI (ed): Histocompatibility Testing 1980. Los Angeles, UCLA Tissue Typing Laboratory, 1980, p 15Google Scholar
  11. 11.
    Svejgaard A, Platz P, Ryder LP: HLA and disease 1982-a survey. Immunol Rev 70: 193–218, 1983PubMedCrossRefGoogle Scholar
  12. 12.
    Pandey JP, Whitten HD, Fudenberg HH: Genetics of human immunoglobulins, in Panayi GS, David CS (eds): Immu¬nogenetics. Boston, Butterworths, 1984, pp 92–109Google Scholar
  13. 13.
    Whittingham S, Mathews JD, Schanfield MS, et al: Interaction of HLA and Gm in autoimmune chronic active hepatitis. Clin Exp Immunol 43: 80–86, 1981PubMedGoogle Scholar
  14. 14.
    Whittingham S, Mathews JP, Schanfield MS, et al: HLA and Gm genes in systemic lupus erythematosus. Tissue Anti¬gens 21: 50–57, 1983CrossRefGoogle Scholar
  15. 15.
    Kagnoff MF, Weiss JB, Brown RJ, et al: Immunoglobulin allotype markers in gluten-sensitive enteropathy. Lancet 1: 952–953, 1983PubMedCrossRefGoogle Scholar
  16. 16.
    Sasazuki T, Nishimura Y, Muto M, et al: HLA-linked genes controlling immune response and disease susceptibility. Immunol Rev 70: 51–75, 1983PubMedCrossRefGoogle Scholar
  17. 17.
    Weitkamp LR, Nee L, Keats B, et al: Alzheimer disease: Evidence for susceptibility loci on chromosome 6 and 14. Am J Hum Genet 35: 443–453, 1983PubMedGoogle Scholar
  18. 18.
    Pandey JP, Fudenberg HH: The HLA supergene and disease. Comp Pathobiol 5: 171 - 182, 1984Google Scholar
  19. 19.
    Sevejgaard A, Morling N, Platz P, et al: HLA and disease, in Fougereau M, Dausset J (eds): Immunology 80. New York, Academic Press, 1980, p 530Google Scholar
  20. 20.
    McIntyre JA, Faulk WP: Recurrent spontaneous abortion in human pregnancy: Results of immunogenetical, cellular, and humoral studies. Am J Reprod Immunol 4: 165–170, 1983PubMedGoogle Scholar
  21. 21.
    Unander AM, Olding LB: Habitual abortion: Parental sharing of HLA antigens, absence of maternal blocking antibody, and suppression of maternal lymphocytes. Am J Reprod Immuno14: 171–178, 1983Google Scholar
  22. 22.
    Ober CL, Martin AO, Simpson JL et al: Shared HLA antigens and reproductive performance among Hutterites. Am J Hum Genet 35: 994–1004, 1983PubMedGoogle Scholar
  23. 23.
    Power DA, Catto GRD, Mason RJ et al: The fetus as an allograft: Evidence for protective antibodies to HLA-linked paternal antigens. Lancet 2: 701–704, 1983PubMedCrossRefGoogle Scholar
  24. 24.
    Svejgaard A, Hauge M, Jersild C, et al: The HLA System. New York, S Karger,1979Google Scholar

Copyright information

© Plenum Publishing Corporation 1985

Authors and Affiliations

  • Janardan P. Pandey

There are no affiliations available

Personalised recommendations